Search
for
Sort by
Research 841–870 of 848
- First National Chemotherapy Safety Standards Issued Jointly by ASCO & ONS
- International Briefs
- Female pattern hair loss: therapeutic update
- Topical Delivery of Atraric Acid Derived from Stereocaulon japonicum with Enhanced Skin Permeation and Hair Regrowth Activity for Androgenic Alopecia
- Showing progress. Defining self-tracking as an aesthetic audio-visual genre
- Patient Satisfaction and Quality of Life Among Adult Women with Androgenetic Alopecia Using 5% Topical Minoxidil.
- One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital
- Tamoxifen-induced androgenetic alopecia in a dialysis patient with sclerosing encapsulating peritonitis (SEP)
- Validation of the Alopecia Areata Patient Priority Outcomes (AAPPO) Questionnaire in Adults and Adolescents with Alopecia Areata
- Érythrodermies néonatales et infantiles : apport de la biopsie cutanée précoce dans les formes graves
- Shared medical appointments for female pattern hair loss
- Complémentarité et équilibre de l’apport alimentaire en protéines et en lipides
- Patient satisfaction with multidisciplinary shared medical appointments for alopecia areata and frontal fibrosing alopecia
- Inhibitory amino acid transmitters associated with axons in presynaptic apposition to cutaneous primary afferent axons in the cat spinal cord
- The influence of peri-incisional triamcinolone acetonide injection on wound edge apposition
- Alopecia Areata–Specific Patient-Reported Outcome Measures
- CO149 Does the EQ-5D Measure the Full Impact of Alopecia Areata on Patients' Health Related Quality of Life?
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA
- BH15 The burden of alopecia areata: examining baseline health-related quality of life and clinical assessment tools
- Patients’ experiences of primary healthcare and dermatology provision for alopecia
- The role of R-spondins and their receptors in bone metabolism
- An Evaluation of Generic and Disease‐Specific Patient‐Reported Outcome Measures to Assess the Impact of Percentage of Scalp Hair Loss on Health‐Related Quality of Life in a European Population
- Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative Study
- 342 Implementation of a teletriage system improves access to dermatologic care in an underserved clinic: A retrospective review
- Rapidly growing hand nodule
- A retrospective review of 12 patients with trichotillomania treated in a psychodermatology service
- HAIR RESTORATION AND AESTHETIC NASAL SURGERY SYMPOSIUM
- 26021 Delivering care for the underserved during COVID-19 through real-time teledermatology, a cross-sectional review of patients at a student-run free clinic in Dallas
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Proliferation and differentiation of organoid hair follicle cells co-cultured with fat cells in collagen gel matrix culture